Zobrazeno 41 - 50
of 201
pro vyhledávání: '"Elena Guerini Rocco"'
Autor:
Tari A. King, Jorge S. Reis-Filho, Neal Rosen, Catherine F. Cowell, Charlotte K.Y. Ng, Dilip Giri, Elena Guerini-Rocco, Victor P. Andrade, Sarat Chandarlapaty, Britta Weigelt, Rita A. Sakr
PDF file - 58KB, PIK3CA mutations and mutation frequencies in pure high-grade DCIS and high-grade DCIS associated with IBC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6df474e705c1d5f579963fc205ca22d5
https://doi.org/10.1158/1078-0432.22450146.v1
https://doi.org/10.1158/1078-0432.22450146.v1
Autor:
Giovanni Corso, Monica Marabelli, Mariarosaria Calvello, Matilde Risti, Irene Feroce, Sara Mannucci, Antonia Girardi, Alessandra De Scalzi, Francesca Magnoni, Elena Marino, Loris Bernard, Paolo Veronesi, Elena Guerini Rocco, Massimo Barberis, Aliana Guerrieri-Gonzaga, Bernardo Bonanni
Metaplastic breast cancer (MpBC) is a rare, aggressive type of breast cancer, often classified as triple negative (TN). Scarce information is available about germline testing in MpBC. We retrospectively reviewed MpBC patients counseled at our Institu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a97d88f28460dad6482ce2300212848a
https://doi.org/10.21203/rs.3.rs-2668559/v1
https://doi.org/10.21203/rs.3.rs-2668559/v1
Publikováno v:
Hereditary Gastric and Breast Cancer Syndrome ISBN: 9783031213168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f43af19a38182d6a48edb63188540cc5
https://doi.org/10.1007/978-3-031-21317-5_11
https://doi.org/10.1007/978-3-031-21317-5_11
Autor:
Francesco Pepe, Elena Guerini-Rocco, Matteo Fassan, Nicola Fusco, Davide Vacirca, Alberto Ranghiero, Konstantinos Venetis, Alessandra Rappa, Sergio Vincenzo Taormina, Gianluca Russo, Elena Rebellato, Giada Munari, Andrea Moreno-Manuel, Carmine De Angelis, Claudio Zamagni, Giorgio Valabrega, Umberto Malapelle, Giancarlo Troncone, Massimo Barberis, Antonino Iaccarino
AimsPoly (ADP-ribose) polymerase (PARP) inhibitors (PARPIs) represent a standard of care for the clinical management of high-grade serous ovarian cancer (HGSOC). The recognition of homologous recombination deficiency (HRD) has emerged as a predictive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f74a1cd9c1f42ea45e09be67758cbb80
https://hdl.handle.net/11588/918509
https://hdl.handle.net/11588/918509
Autor:
Elena Guerini Rocco, Caterina Fumagalli, Alberto Concardi, Sergio V. Taormina, Aliana Guerrieri-Gonzaga, Federica Corso, Sara Gandini, Bernardo Bonanni, Giuseppe Viale, Massimo Barberis, Nicola Fusco, Lazzeroni Matteo
Publikováno v:
Cancer Research. 82:P1-22
Background. Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer (IBC). High variability in clinical outcomes and propensity for invasion among DCIS is reported, but identifying high-risk DCIS remains a major clinical
Autor:
Nicola Fusco, Elham Sajjadi, Konstantinos Venetis, Barbara Buonomo, Concetta Blundo, Massimo Giroda, Eugenia Di Loreto, Giovanna Scarfone, Stefano Ferrero, Paolo Veronesi, Viviana E. Galimberti, Massimo Barberis, Giuseppe Viale, Elena Guerini-Rocco, Fedro A. Peccatori
Publikováno v:
Cancer Research. 82:P4-07
Introduction: Breast cancer during pregnancy (PrBC) accounts for ~4% of breast cancer cases in young women and its intrinsic biology is still largely undetermined. Tumor microenvironment (TME) of PrBC has been recently characterized with low levels o
Autor:
Nicola Fusco, Elham Sajjadi, Konstantinos Venetis, Marco Invernizzi, Donatella Gambini, Letterio Runza, Stefano Ferrero, Elena Guerini-Rocco
Publikováno v:
Cancer Research. 82:P4-10
Background: The activity impairment of Phosphatase and tensin homolog (PTEN), a tumor suppressor and negative regulator of the PI3K/Akt pathway, is associated with tumorigenesis, tumor progression, and therapy resistance in breast cancer. However, th
Autor:
Nicola Fusco, Concetta Blundo, Massimo Giroda, Elham Sajjadi, Konstantinos Venetis, M. Cristina Leonardi, Elisa Vicini, Luca Despini, Claudia F. Rossi, Letterio Runza, Eugenia Di Loreto, Giovanna Scarfone, Elena Guerini-Rocco, Giuseppe Viale, Paolo Veronesi, Barbara Buonomo, Fedro A. Peccatori, Viviana E. Galimberti
Publikováno v:
Cancer Research. 82:P3-18
Background: Breast cancer is the most common malignancy occurring during gestation and should be managed with the same protocols as for young non-pregnant women. In early-stage breast cancer during pregnancy (PrBC), breast-conserving surgery (BCS) wi
Autor:
Zheqi Li, Yang Wu, Megan E. Yates, Nilgun Tasdemir, Amir Bahreini, Jian Chen, Kevin M. Levine, Nolan M. Priedigkeit, Azadeh Nasrazadani, Simak Ali, Laki Buluwela, Spencer Arnesen, Jason Gertz, Jennifer K. Richer, Benjamin Troness, Dorraya El-Ashry, Qiang Zhang, Lorenzo Gerratana, Youbin Zhang, Massimo Cristofanilli, Maritza A. Montanez, Prithu Sundd, Callen T. Wallace, Simon C. Watkins, Caterina Fumagalli, Elena Guerini-Rocco, Li Zhu, George C. Tseng, Nikhil Wagle, Jason S. Carroll, Paul Jank, Carsten Denkert, Maria M. Karsten, Jens-Uwe Blohmer, Ben H. Park, Peter C. Lucas, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich
Publikováno v:
Cancer Res
Constitutively active estrogen receptor α (ER/ESR1) mutations have been identified in approximately one-third of ER+ metastatic breast cancers. Although these mutations are known as mediators of endocrine resistance, their potential role in promotin
Autor:
Gabriella Schivardi, Luigi Antonio de Vitis, Caterina Fumagalli, Paola Rafaniello Raviele, Maria Teresa Achilarre, Alessia Aloisi, Annalisa Garbi, Mariateresa Lapresa, Gabriella Parma, Vanna Zanagnolo, Giovanni Damiano Aletti, Elena Guerini-Rocco, Andrea Mariani, Angelo Maggioni, Massimo Barberis, Nicoletta Colombo, Ilaria Betella, Francesco Multinu
Publikováno v:
Endometrial cancer.